Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 18 filings·Updated 30 Sept 2026
Showing 10 of 18 filings.
30 Sept 20261 filing
AGM/EGMAGM

31st AGM held Sept 30, 2026; ordinary resolution to adopt Audited Financial Statements.

AGM Details

  • 31st AGM held on 30 September 2026 at 12:30 PM IST in physical mode at Chennai.

Key Resolutions

  • Ordinary: adopt Audited Financial Statements for the year ended March 31, 2026.

Voting Results

  • Results pending; Scrutinizer's report awaited and results to be announced.
Filed 16:06View Source
29 Sept 20263 filings
Insider Trading / SASTClosure of Trading Window

Sanguine Media Ltd — Closure of Trading Window from Oct 01, 2026 till 48 hours after the declaration of its Unaudited Financial Results for the Quarter ended September 30, 2026.

Sanguine Media Ltd — Closure of Trading Window from Oct 01, 2026 till 48 hours after the declaration of its Unaudited Financial Results for the Quarter ended September 30, 2026.

Filed 14:33View Source
OthersReg. 34 (1) Annual Report

Sanguine Media Limited 2025-26: Revenue Rs 9.53 Lakh; net loss Rs 0.41 Lakh; AGM on 30 Sep 2026; governance gaps noted

Financial snapshot

  • Revenue 9.53 Lakhs, down from 12.25 Lakhs prior year.
  • Net loss for 2025-26 is 0.41 Lakhs.
  • Profit before tax is (0.41) Lakhs.
  • Profit after tax mirrors the pre-tax loss at (0.41) Lakhs.
  • Basic EPS is (0.000) Rs.

Assets and liabilities

  • Non-current investments 644.80 Lakhs; Loans 5,654.40 Lakhs.
  • Inventories 1,260.15 Lakhs; Trade receivables 1,530.43 Lakhs.
  • Cash and bank balance 12.88 Lakhs; Total current assets 6,009.90 Lakhs.
  • Total assets 12,309.10 Lakhs; Total equity 12,134.41 Lakhs.
  • Borrowings 133.50 Lakhs; Trade payables 41.18 Lakhs.

Capital structure & liquidity

  • Equity share capital 11,410.00 Lakhs; total equity 12,134.41 Lakhs.
  • Debt consists of short-term borrowings with 133.50 Lakhs; no long-term debt.
  • Current ratio reported at 34.40x.
  • Dividend for FY2025-26 not recommended.

Dividend & AGM

  • Board did not declare a dividend for 2025-26.
  • 31st AGM to be held on 30 September 2026 at registered office.
  • Remote e-voting from 27 to 29 September 2026; cut-off 23 September 2026.

Governance & audit

  • Statutory auditors: K. S. Subramanyam & Co.; Secretarial auditor: Chirag Jain.
  • Secretarial audit flags governance gaps including no Company Secretary during year.
  • Auditors issued unmodified report; no fraud reported.
  • Board met five times in the year; independent directors meetings held.

Shareholding & dematerialisation

  • Largest holders: Bodies Corporate 32.56%; LLP 11.26%; individuals 19.47% and 25.18%.
  • Total equity shares: 114.10 million; par value Rs 10 each.
  • Dematerialisation: NSDL 32.23%; CDSL 67.71%; Physical 0.06%.

Outlook and risks

  • Industry outlook positive with growth in digital platforms and original content.
  • Esports trend noted as growth opportunity; rising digital advertising share.
  • Competitive pressures and ad spend to GDP ratio pose risks.

Subsidiaries, related party and compliance

  • No subsidiary or joint venture; no material related party transactions in year.
  • Policy on material subsidiary disclosed on website; related party disclosures in notes.
  • Governance and compliance calendar flagged as areas for improvement by Secretarial Auditor.
Filed 12:17View Source
AGM/EGMAGM

Sanguine Media announces 31st AGM to adopt FY2025-26 financials and reappoint executive director

AGM Details

  • 31st AGM scheduled for 30 September 2026 at 12:30 PM IST at the registered office.
  • Meeting will be conducted with remote e-voting facility.
  • Register of Members and Share Transfer Books remain closed 24-30 September 2026.
  • Remote e-voting window from 27 September 2026, 9:00 AM to 29 September 2026, 5:00 PM.
  • Voting eligibility cut-off date is 23 September 2026.
  • Notice and annual report available on company website and NSDL/stock exchange portals.

Resolutions

  • Ordinary Resolution: adoption of audited financial statements for FY 2025-26 and related reports.
  • Ordinary Resolution: re-appointment of Mr. Sanjay Sunderlal Meena as Executive Director.

Directors

  • Mr. Sanjay Sunderlal Meena retires by rotation and is proposed for re-appointment.

Auditors

  • Statutory auditors: KS Subramanyam & Co., Chartered Accountants.
  • Secretarial auditor: Chirag Jain, Practising Company Secretary.
Filed 12:11View Source
11 Aug 20261 filing
Board MeetingOutcome of Board Meeting

Sanguine Media approves unaudited quarterly results for quarter ended 30 June 2026 with Limited Review Report

Key financial results and board actions

  • Board approved unaudited quarterly results for quarter ended 30 June 2026 with Limited Review Report.
  • Revenue from operations (unaudited) 0.00 for the quarter ended 30 June 2026.
  • Total income 1.66 for the quarter ended 30 June 2026.
  • Profit after tax for the quarter ended 30 June 2026: 0.06.
  • Audit Committee reviewed results; Board approved the outcomes.
  • No separate segment information disclosed due to single primary business segment.

Other disclosures

  • Reviewed the company’s other businesses as part of the board’s discussions.
Filed 16:15View Source
7 Aug 20261 filing
Board Meeting

Sanguine Media board to consider unaudited quarter ended 30 June 2026 results on 11 August 2026

Meeting Details

  • Date: 11 August 2026; Time not disclosed; Location: Registered Office, Sanguine Media Limited.

Key Agenda Items

  • Unaudited quarterly results for the quarter ended 30 June 2026, with Auditor's Limited Review Report.

Other Notes

  • Trading window closure periods are not specified.
Filed 18:22View Source
14 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate confirms dematerialisation processed; securities listed; ownership updated within timeline

Dematerialisation/rematerialisation status

  • Dematerialisation requests processed during the quarter; accepted/rejected and listed on exchanges.
  • Physical certificates for dematerialisation mutilated and cancelled after verification; depository registered owner substitution completed within prescribed timelines.
  • Securities dematerialised/rematerialised listed on the stock exchanges.
Filed 18:01View Source
30 Jun 20261 filing
Insider Trading / SASTClosure of Trading Window

Sanguine Media Ltd closes trading window from July 01, 2026 till 48 hours after the declaration of its Unaudited Financial Results for the Quarter ended June 30, 2026

Sanguine Media Ltd closes trading window from July 01, 2026 till 48 hours after the declaration of its Unaudited Financial Results for the Quarter ended June 30, 2026

Filed 17:02View Source
15 Apr 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Reg 74(5)

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 17:15View Source
24 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

Closure of Trading Window

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 19:14View Source
Showing 10 of 18 filings